Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - April 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 24 April 2026, 09:30 (CEST) to 24 April 2026, 11:30 (CEST)

Introductory cover note to the list of European Union reference dates and frequency of submission of periodic safety update reports

Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - March 2026, Online, European Medicines Agency, Amsterdam, the Netherlands, from 23 March 2026, 10:00 (CET) to 23 March 2026, 12:00 (CET)

Overview of comments received on the draft Qualification opinion for Molecule-independent device bridging approach (MIDBA)

Qualification opinion for Molecule-independent device bridging approach (MIDBA)

Electronic product information (ePI) roadmap

Human medicines European public assessment report (EPAR): SonoVue, sulphur hexafluoride, Date of authorisation: 26/03/2001, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Xgeva, denosumab, Date of authorisation: 13/07/2011, Revision: 28, Status: Authorised

Human medicines European public assessment report (EPAR): Aerius, desloratadine, Date of authorisation: 15/01/2001, Revision: 53, Status: Authorised

Human medicines European public assessment report (EPAR): Neoclarityn, desloratadine, Date of authorisation: 15/01/2001, Revision: 49, Status: Authorised